American Society For Nutrition

Continuing Education Credits

Continuing Education Credits

Excellence in Nutrition Research and Practice

Learning Objectives

Upon completion of this educational activity, participants should be able to describe and discuss:

• Nutrition and medical management of patients with obesity and chronic disease

• Impact of dietary supplements for patients with chronic disease
• How diet impacts the aging process

• How to interpret research to design medical approach, diet, and behavior modification for patients of various ages and

health

• What constitutes a healthy diet for all and use this information to develop programs for patients

Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the University of Maryland School of Medicine and the American Society for Nutrition. The University of Maryland School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for

physicians.

CPE Credit Designation Statement

ASN designates this educational activity for a maximum of 4.5 CPEUs. Dietitians and dietetic technicians, registered should only claim credit commensurate with the extent of their participation in the activity.

ASN (Provider #NS010) is accredited and approved by the Commission on Dietetic Registration (CDR) as a provider of Continuing Professional Education (CPE) programs for Registered Dietitians.

Learning Level 2


Suggested Learning Codes:

2000: Science of Food and Nutrition

4030: Wellness and Public Health/Dietary Guidelines, DRIs, etc.

5190: Diabetes mellitus

9020: Evaluation and application of research


Disclosure

It is the policy of the University of Maryland School of Medicine to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, all persons in a position to control activity content of continuing medical education activities must disclose their financial relationships with commercial interests relevant to the content of the CME activity. Any conflicts of interest identified must be resolved prior to presentation of the educational activity.

The following individuals have disclosed no financial relationships with commercial interests:

Michael Alderman, MD; Daniel H. Bessesen, MD; Connie W. Bales, PhD, RD; Paul M. Coates, PhD; Margaret Furtado, MS, RD, LDN; Jesse F. Gregory, PhD; David Heber, MD, PhD; Mary Ann Johnson, MD; Nancy F. Krebs, MD; Robert Kushner, MD; Joel B. Mason, MD; Richard D. Mattes, MPH, PhD, RD; K. Sreekumaran Nair, MD, PhD; Mark A. Pereira, PhD; Anastassios G. Pittas, MD, MS; Susan B. Roberts, PhD, Robert M. Russell, MD, Edward Saltzman, MD; Nanette Steinle, MD; Patrick Stover, PhD; and Thomas Ziegler, MD


CME Credit Designation Statement


The University of Maryland School of Medicine designates this educational activity for a maximum of 14.50 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CPE Credit Designation Statement

ASN designates this educational activity for a maximum of 14 CPEUs. Dietitians and dietetic technicians, registered should only claim credit commensurate with the extent of their participation in the activity.


Advances and Controversies in Clinical Nutrition conference has been approved for 13 Category 1 continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing.

Faculty Disclosure

It is the policy of the University of Maryland School of Medicine to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, all persons in a position to control activity content of continuing medical education activities must disclose their financial relationships with commercial interests relevant to the content of the CME activity. Any conflicts of interest identified must be resolved prior to presentation of the educational activity.

Americans With Disabilities Act

If you require special accommodations to attend or participate in this CME activity, please provide information about your requirements to Katrina Dunn at 301-634-7043 or (1-800-735-2258 TTY/voice) at least five business days in advance of the activity.

Discussion of Off-Label or Investigational Uses

Presentations in this continuing medical education activity may contain references to unlabeled or unapproved uses of drugs or devices. The audience is advised to consult the full prescribing information of all drugs or devices prior to use. Some drugs/devices identified during this activity may have United States Food and Drug Administration (FDA) clearance for specific purposes only or for use in restricted research settings. The FDA has stated that it is the responsibility of the individual physician to determine the FDA status of each drug or device that he/she wishes to use in clinical practice and to use the products in compliance with the applicable law.

UMSOM requires that all contributors disclose any unlabeled use or investigational use (not yet approved for any purpose) of pharmaceutical and medical device products and provide adequate scientific and clinical justification for such use. Physicians are urged to fully review all the available data on products or procedures before using them to treat patients.

Disclaimer

This CME activity is designed for use by healthcare professionals for educational purposes only. Information and opinions offered by the contributors represent their viewpoints. Conclusions drawn by the participant should be derived from careful consideration of all available scientific information. Prescription information and use of medical devices should be undertaken only after confirmation of information by consulting the FDA-approved uses and information.

While UMSOM makes every effort to have accurate information presented, no warranty, expressed or implied, is offered. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others.

Acknowledgement of Support

The following institutions, organizations, and/or companies have provided educational grants in support of the ASN Advances and Controversies in Clinical Nutrition conference, as of press time: American Institute for Cancer Research; Corn Refiners Association; Dyets; FDA – San Francisco District Office; and Solae.

CPE Accreditation Statement

ASN (Provider #NS010) is accredited and approved by the Commission on Dietetic Registration (CDR) as a provider of Continuing Professional Education (CPE) programs for Registered Dietitians.

CME Sponsorship

This activity is jointly sponsored by the University of Maryland School of Medicine and the American Society for Nutrition.

CPE Credit

ASN (Provider #NS010) is accredited and approved by the Commission on Dietetic Registration (CDR) as a provider of Continuing Professional Education (CPE) programs for Registered Dietitians.

Number of CPE Credits: 14 CPEUs

Learning Level 2

Suggested Learning Codes: TBD

If you have questions about CPE credit, please contact Moira Holt at mholt@nutrition.org


Continuing Education Contact Hours (CECH) in Health Education

Advances and Controversies in Clinical Nutrition conference has been approved for 13 Category 1 continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing. This means that we can provide continuing education credit to 8,000+ Certified Health Education Specialists who may be interested in the conference.


Other Continuing Education Credit and Letters of Participation

If you are not a physician or dietitian and seek continuing education credit or require a letter confirming your participation, please contact us. You may contact Moira Holt at mholt@nutrition.org with these inquiries.